Delivery Order SPE2DB24D8002-SPE2DB25FJNSR
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,346.71 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products to support U.S. Armed Forces medical operations. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,830.16, is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products to support U.S. Armed Forces medical operations. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) vehicle with a ceiling value of...
This is a $6,331.52 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, with a performance period ending on January 15, 2025. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT Generation V Program, which allows the company to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,128.03 contract is for the delivery of Fluticasone-Salmeterol 500-50 60s, a pharmaceutical product used to treat respiratory conditions. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with DLA Troop Support Medical's ECAT...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,476.84, is for the delivery of Fluticasone-Salmeterol 45-21 12GM, a pharmaceutical product. The contract does not have a set-aside designation and is set to be completed by October 29, 2024. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a range of pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,390.59, is for the delivery of Fluticasone-Salmeterol 250-50 60s medication. It is a firm fixed-price contract with an ultimate completion date of April 30, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,828.37 firm fixed-price contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract is not set aside and is part of Dakota Drug, Inc.'s $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $2,019.87 firm fixed-price contract is for the delivery of the pharmaceutical product fluticasone-salmeterol 230-21 12GM. The contract is not set aside and is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) valued at $999,999,999.00 that allows...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government. The contract, valued at $7,225.70, is a firm fixed-price delivery order for the supply of Fluticasone-Salmeterol 115-21 12GM inhalers. The award is associated with a larger Indefinite Delivery Contract (IDC) between Dakota...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,553.05, is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, to support U.S. Armed Forces medical operations. The contract is a firm fixed-price, non-set-aside award with a completion date of January 28, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract...